News on epigenetic profiling, DNA methylation, histone modifications, epigenetic disorders in genetics, genomics, and molecular diagnostics.
The company plans to use the funds to support expansion of its commercial footprint by increasing sales and marketing efforts and new technology development.
MDxHealth will use Ghent's methylation in situ hybridization technology to develop tests for urological cancers.
